The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

Janet K. Parrish, Tyler S. McCann, Marybeth Sechler, Lays M. Sobral, Wenhua Ren, Kenneth L. Jones, Aik Choon Tan, Paul Jedlicka

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry